Skip to main content

Want a detailed portfolio tracker?

Cytokinetics (CYTK) P/E (2006 - 2026)

Cytokinetics (CYTK) P/E from Mar 31, 2006 to Jul 21, 2026. The TTM Cytokinetics (CYTK) P/E is -11.85. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Cytokinetics (CYTK)

YearP/EChange
2026-11.85+21.88%
2025-9.73+9.11%
2024-8.91-41.06%
2023-15.12+4.45%
2022-14.48-10.11%
2021-16.11+56.21%
2020-10.31+105.42%
2019-5.02+55.18%
2018-3.23-33.97%
2017-4.90-95.75%
2016-115.36+965.64%
2015-10.83-42.12%
2014-18.70+282.14%
2013-4.89+193.55%
2012-1.67+19.36%
2011-1.40-48.70%
2010-2.72-141.05%
20096.63-363.56%
2008-2.52-45.38%
2007-4.61-29.22%
2006-6.51N/A

Comparison Cytokinetics (CYTK) P/E with competitors

Cytokinetics (CYTK) P/E is -11.85.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.04%
ENLVEnlivex Ltd0.07-100.63%
FGENFibroGen Inc0.24-102.03%
CHRSCoherus Biosciences Inc0.85-107.16%
FBIOFortress Biotech Inc0.95-108.01%
ORMPOramed Pharmaceuticals Inc1.50-112.68%
AGENAgenus Inc3.01-125.39%
INVAInnoviva Inc3.15-126.61%
VXRTVaxart Inc3.55-129.95%
CRMDCorMedix Inc3.63-130.61%
CVACCureVac N.V.4.45-137.51%
GLPGGalapagos NV4.86-140.99%
SRPTSarepta Therapeutics Inc4.88-141.19%
ABEOAbeona Therapeutics Inc5.39-145.45%
ABUSArbutus Biopharma Corp5.60-147.21%
ZVRAZevra Therapeutics Inc5.89-149.67%
SPROSpero Therapeutics Inc6.23-152.55%
CGENCompugen Ltd6.31-153.27%
RIGLRigel Pharmaceuticals6.87-157.98%
SLXNSilexion Therapeutics Corp7.30-161.55%
OMEROmeros Corporation9.26-178.11%
AUPHAurinia Pharmaceuticals Inc9.58-180.86%
PLXProtalix BioTherapeutics Inc10.89-191.88%
ACADAcadia Pharmaceuticals Inc11.73-198.95%
TBPHTheravance Biopharma Inc12.26-203.45%
ADMAAdma Biologics Inc12.42-204.76%
HRMYHarmony Biosciences Holdings Inc13.82-216.59%
SABSSAB Biotherapeutics Inc14.14-219.26%
NAGENiagen Bioscience Inc14.82-225.01%
INCYIncyte Corp15.82-233.48%
REGNRegeneron Pharmaceuticals Inc15.86-233.77%
PBYIPuma Biotechnology Inc17.32-246.08%
CPRXCatalyst Pharmaceuticals Inc17.44-247.12%
EXELExelixis Inc17.54-247.96%
TGTXTG Therapeutics Inc18.97-260.00%
MDXGMimedx Group Inc20.55-273.39%
XOMAXOMA Royalty Corp22.87-292.98%
ARGXArgen X SE24.30-304.99%
CTMXCytomX Therapeutics Inc24.82-309.41%
XOMAOXOMA Royalty Corp25.34-313.82%
HALOHalozyme Therapeutics Inc25.62-316.18%
XOMAPXOMA Royalty Corp25.67-316.57%
VRTXVertex Pharmaceuticals Inc27.99-336.18%
RPRXRoyalty Pharma plc - Class A28.69-342.03%
SLNOSoleno Therapeutics Inc29.02-344.79%
ASNDAscendis Pharma A/S30.09-353.82%
LGNDLigand Pharmaceuticals Inc - Class B37.91-419.85%
APLSApellis Pharmaceuticals Inc39.02-429.21%
BMRNBiomarin Pharmaceutical Inc42.21-456.12%
KRYSKrystal Biotech Inc45.34-482.54%
ONCBeiGene Ltd69.54-686.69%
PHARPharming Group N.V.75.03-732.96%
TECHBio-Techne Corp101.96-960.18%
VCELVericel Corp109.92-1027.36%
ALNYAlnylam Pharmaceuticals Inc117.96-1095.22%
GMABGenmab140.29-1283.58%
TLXTelix Pharmaceuticals Ltd162.15-1468.02%
CORTCorcept Therapeutics Inc212.86-1895.79%